# Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations

> **NCT07494981** · — · NOT_YET_RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Ceftazidime-avibactam

## Interventions

- **DIAGNOSTIC_TEST:** liquid chromatography-tandem mass spectrometry

## Key facts

- **NCT ID:** NCT07494981
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-25
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07494981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07494981, "Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07494981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*